AMY LAKE: Open Payments
NPI 1962966341 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 20 payments from 8 companies in 2025. Trend: 2023 $693 · 2024 $360 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $154 |
| Astellas Pharma US Inc | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Hologic Sales and Service, LLC | 2 | $39 |
| Dexcom, Inc. | 1 | $24 |
| CooperSurgical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: ZURZUVAE, Veozah, Mirena, Dexcom G6 Transmitter, NOVASURE, Paragard T 380A, Auvelity, ACESSA PROVU SYSTEM.
Industry payments across IN — which companies pay providers there.
